Literature DB >> 16781233

Bare metal stent restenosis is not a benign clinical entity.

Michael S Chen1, Jim M John, Derek P Chew, David S Lee, Stephen G Ellis, Deepak L Bhatt.   

Abstract

BACKGROUND: Restenosis after percutaneous coronary intervention (PCI) has been thought to present in a stable manner as exertional angina. However, the presentation of in-stent restenosis (ISR) is not well-studied. We hypothesized that a substantial proportion of bare metal ISR presents as acute coronary syndromes. We aimed to characterize the severity of the clinical presentation of ISR.
METHODS: We searched our PCI database for all cases of PCI for bare metal ISR occurring between May 1999 and September 2003. Multivessel interventions were excluded. In-stent restenosis presentation was classified into three categories: (1) myocardial infarction (MI), (2) unstable angina requiring hospitalization before angiography, and (3) exertional angina. Routine angiographic screening after initial stent placement was not performed, so ISR episodes were clinical, rather than angiographic, ISR.
RESULTS: We identified 1186 cases of bare metal ISR in 984 patients. Median age was 63, 72% were male, and 36% had diabetes. Of the ISR episodes, 9.5% presented as acute MI (7.3% as non-ST-segment elevation MI and 2.2% as ST-segment elevation MI), 26.4% as unstable angina requiring hospitalization before angiography, and 64.1% as exertional angina.
CONCLUSIONS: More than one third of bare metal ISR episodes presented as MI or unstable angina requiring hospitalization. The acuity of the clinical presentation of bare metal ISR appears to be more severe than has been previously thought. Aggressive efforts, such as drug-eluting stents to decrease the incidence of unstable angina due to bare metal ISR, are warranted.

Entities:  

Mesh:

Year:  2006        PMID: 16781233     DOI: 10.1016/j.ahj.2005.08.011

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  63 in total

Review 1.  Long-term outcome of percutaneous coronary intervention: the significance of native coronary artery disease progression.

Authors:  Athanasios Moulias; Dimitrios Alexopoulos
Journal:  Clin Cardiol       Date:  2011-09-19       Impact factor: 2.882

2.  A meta-analysis of randomized trials on clinical outcomes of paclitaxel-eluting stents versus bare-metal stents in ST-segment elevation myocardial infarction patients.

Authors:  Xiao-hong Pan; Ying-xue Chen; Mei-xiang Xiang; Geng Xu; Jian-an Wang
Journal:  J Zhejiang Univ Sci B       Date:  2010-10       Impact factor: 3.066

3.  Very late thrombosis in a bare metal stent: an under-recognized problem.

Authors:  Massimo Fineschi; Tommaso Gori
Journal:  Can J Cardiol       Date:  2008-02       Impact factor: 5.223

4.  Parametric Optimization of 3D Printed Hydrogel-Based Cardiovascular Stent.

Authors:  Krishna Veerubhotla; Yugyung Lee; Chi H Lee
Journal:  Pharm Res       Date:  2021-05-10       Impact factor: 4.200

5.  Mis-sizing of stent promotes intimal hyperplasia: impact of endothelial shear and intramural stress.

Authors:  Henry Y Chen; Anjan K Sinha; Jenny S Choy; Hai Zheng; Michael Sturek; Brian Bigelow; Deepak L Bhatt; Ghassan S Kassab
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-09-16       Impact factor: 4.733

Review 6.  Postoperative care and follow-up after coronary stenting.

Authors:  Tienush Rassaf; Stephan Steiner; Malte Kelm
Journal:  Dtsch Arztebl Int       Date:  2013-02-01       Impact factor: 5.594

7.  Small molecule agonists of integrin CD11b/CD18 do not induce global conformational changes and are significantly better than activating antibodies in reducing vascular injury.

Authors:  Mohd Hafeez Faridi; Mehmet M Altintas; Camilo Gomez; Juan Camilo Duque; Roberto I Vazquez-Padron; Vineet Gupta
Journal:  Biochim Biophys Acta       Date:  2013-02-26

8.  Long-term clinical outcomes after drug-eluting and bare-metal stenting in Massachusetts.

Authors:  Laura Mauri; Treacy S Silbaugh; Robert E Wolf; Katya Zelevinsky; Ann Lovett; Zheng Zhou; Frederic S Resnic; Sharon-Lise T Normand
Journal:  Circulation       Date:  2008-10-13       Impact factor: 29.690

Review 9.  Another view of personalized medicine: optimizing stent selection on the basis of predicted benefit in percutaneous coronary intervention.

Authors:  Neil J Wimmer; Robert W Yeh
Journal:  Trends Cardiovasc Med       Date:  2012-07-28       Impact factor: 6.677

10.  Endothelial cell migration on RGD-peptide-containing PEG hydrogels in the presence of sphingosine 1-phosphate.

Authors:  Bradley K Wacker; Shannon K Alford; Evan A Scott; Meghna Das Thakur; Gregory D Longmore; Donald L Elbert
Journal:  Biophys J       Date:  2007-09-07       Impact factor: 4.033

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.